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Abstract Recognition of DNA viruses, such as cytomegaloviruses (CMVs), through pattern-
recognition receptor (PRR) pathways involving MyD88 or STING constitute a first-line defense
against infections mainly through production of type I interferon (IFN-I). However, the role of these
pathways in different tissues is incompletely understood, an issue particularly relevant to the CMVs
which have broad tissue tropisms. Herein, we contrasted anti-viral effects of MyD88 versus STING
in distinct cell types that are infected with murine CMV (MCMV). Bone marrow chimeras revealed
STING-mediated MCMV control in hematological cells, similar to MyD88. However, unlike MyD88,
STING also contributed to viral control in non-hematological, stromal cells. Infected splenic stromal
cells produced IFN-I in a cGAS-STING-dependent and MyD88-independent manner, while we
confirmed plasmacytoid dendritic cell IFN-I had inverse requirements. MCMV-induced natural killer
cytotoxicity was dependent on MyD88 and STING. Thus, MyD88 and STING contribute to MCMV
control in distinct cell types that initiate downstream immune responses.
Introduction
Viral infections can be detected by specialized pattern recognition receptors, which recognize viral
structures that are unique or otherwise absent in the subcellular location where they are detected.
Nucleic acids from DNA-viruses can be detected in various organelles during infection. Some DNA
viruses pass through endolysosomes where viral DNA can be recognized by toll-like receptors
(TLRs), in particular TLR9, which signals through MyD88 and induces a type I interferon (IFN-I)
response (Hemmi et al., 2000; Motwani et al., 2019). In the cytosol, infection results in exposure of
viral DNA that can be recognized by cytosolic DNA sensors including cyclic GMP-AMP synthase
(cGAS) and absent in melanoma 2 (AIM2) inflammasome (Bürckstümmer et al., 2009;
Schoggins et al., 2014; Sun et al., 2013; Tan et al., 2018). cGAS signals through STING and ini-
tiates an IFN-I response, whereas AIM2 activates caspase I and instigates an IL-1b and IL-18
responses. The TLRs and AIM2 pathways are primarily active in specific immune cell types. In con-
trast, the STING-cGAS pathway appear to be active in a broader range but not all cell types
(Motwani et al., 2019; Thomsen et al., 2016). Yet, it is unclear how activation of these pathways in
different cell types contributes to viral control.
The IFN-I that is produced in response to viral recognition plays a central role in protection
against acute infection. IFN-I mediates its anti-viral effects through stimulation of the interferon
receptor, comprising of IFNAR1 and IFNAR2, and downstream STAT molecules. The resulting IFN-
stimulated genes (ISGs) induce an anti-viral state, affecting cell survival and viral replication
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(González-Navajas et al., 2012; McNab et al., 2015). In addition, IFN-I is critical for orchestrating
the subsequent innate and adaptive immune responses, through modulation of cell attraction, acti-
vation, and priming. Although human deficiencies in the IFN-I pathway are very rare, evidence sug-
gest that IFN-I could protect against viral infections in humans. Individuals with mutations in IFNAR2
and STAT2 have relatively mild symptoms after infection, even though they can develop severe ill-
ness in response to live vaccines and can have recurrent viral infections (Duncan et al., 2015;
Hambleton et al., 2013; Moens et al., 2017). However, these deficiencies likely do not completely
nullify IFN-I effects because IFNb can signal through IFNAR1 without requiring IFNAR2 and IFN-I can
signal through STAT2-independent pathways (de Weerd et al., 2013; González-Navajas et al.,
2012). In addition, other loss-of-function mutations that affect the IFN-I pathway have been
described to enhance susceptibility to virus infection, including IRF7, IRF3, IRF9, and STAT1
(Andersen et al., 2015; Bravo Garcı́a-Morato et al., 2019; Chapgier et al., 2009;
Ciancanelli et al., 2015; Hernandez et al., 2018; Kong et al., 2010; Thomsen et al., 2019a;
Thomsen et al., 2019b). Thus, IFN-I is critical to control viral infections, but it remains unclear what
pathways contribute to viral control.
In this regard, studies of infections with the beta-herpesvirus cytomegalovirus (CMV), have been
informative. Infection with human CMV (HCMV) is nearly ubiquitous worldwide (Cannon et al.,
2010). HCMV is controlled and establishes latency in healthy individuals, but HCMV can cause life-
threatening disease in immunocompromised patients (Griffiths et al., 2015). Despite a broad tro-
pism that allows CMV to infect a wide range of cell types, CMV is highly species-specific
(Krmpotic et al., 2003; Sinzger et al., 2008). Murine CMV (MCMV) in particular shares key features
with HCMV and has been instructive for dissecting cytomegalovirus pathogenesis (Krmpotic et al.,
2003; Picarda and Benedict, 2018). Indeed, a recent case study described a patient with deficien-
cies in both IFNAR1 and IFNGR2 who presented with bacteremia and CMV viremia (Hoyos-
Bachiloglu et al., 2017). Consistent with these findings, mice deficient in Ifnar1 and Ifngr1 are highly
susceptible to MCMV in 129Sv and C57BL/6 strains (Gil et al., 2001; Presti et al., 1998). Ifnar1 defi-
ciency in isolation resulted in a 100-fold increased MCMV susceptibility whereas Ifngr1 deficiency
did not, indicating that IFN-I plays a dominant role in controlling acute CMV infections. IFN-I produc-
tion during acute MCMV infection is biphasic; initial IFN-I production peaks at 8 hr post infection (p.
i.) with a second peak at 36–48 hours p.i. (Delale et al., 2005; Schneider et al., 2008). STING has
been implicated in the initial IFN-I response. STING-deficient mice have decreased systemic IFNb at
12 hours p.i. and 5-fold increased viral load at 36 hours p.i. (Lio et al., 2016). A recent study impli-
cated Kupffer cells to be the main source for IFNb in the liver 4 hours p.i. (Tegtmeyer et al., 2019).
Besides the aforementioned immune cells, stromal cells are thought to be a major source for IFN-I in
the spleen at 8 hours p.i. (Schneider et al., 2008). By contrast, MyD88-dependent pathways have
been implicated in IFN-I production during the second wave (Delale et al., 2005; Krug et al.,
2004). IFN-I production by plasmacytoid dendritic cells (pDCs) is dependent on TLR7 and TLR9
(Hokeness-Antonelli et al., 2007; Krug et al., 2004; Zucchini et al., 2008b). Consistent with the
role of pDCs in IFN-I production, MyD88 is required in the hematological compartment in bone mar-
row chimeras (Puttur et al., 2016). However, it has been unknown which sensing pathway is respon-
sible for IFN-I induction in the stroma and how each contributes to control MCMV infection in
different tissues.
Besides its direct anti-viral effects, IFN-I is crucial for optimal NK cell function during viral infection
(Orange and Biron, 1996). NK cells play a critical role in controlling MCMV infection in C57BL/6
mice, which is dependent on interactions between the Ly49H NK cell activation receptor and its
MCMV-encoded ligand m157 (Arase et al., 2002; Brown et al., 2001; Smith et al., 2002). How-
ever, this interaction is not sufficient to allow NK cell control of MCMV infection. IL-12 and IFN-I pro-
duced early during MCMV infection induce granzyme B and perforin protein expression in NK cells
(Fehniger et al., 2007; Nguyen et al., 2002; Parikh et al., 2015), which allows them to efficiently
kill virus-infected cells upon recognition of m157 through Ly49H (Parikh et al., 2015). IL-12 and
IFN-I also induce IFNg transcription, which is required for activation receptor-dependent IFNg pro-
duction (Piersma et al., 2019). In the absence of MyD88, Ly49H+ NK cells can compensate for sub-
optimal IFN-I production (Cocita et al., 2015), suggesting that low levels of IFN-I can still enhance
NK-mediated control of MCMV. However, which MCMV-sensing pathway contributes to the NK cell
response is still unclear.
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In the current study, we analyzed survival, viral titers, IFN-I production and NK cell responses in
mice deficient in MyD88, STING or both. We also determined the contribution of both signaling
pathways in different tissues to their anti-viral effects, and elucidated a role for cGAS in these
responses.
Results
MyD88 and STING-dependent pathways control MCMV infection in
vivo
We set out to investigate the relative contribution of STING- versus MyD88-dependent pathways in
controlling MCMV infection by analyzing the morbidity and mortality in wildtype C57BL/6 (WT),
MyD88-deficient (MyD88 KO), and STING-deficient (STING GT) mice as well as mice deficient in
both MyD88 and STING (DKO) that were infected with 50,000 PFU MCMV (Figure 1). Consistent
with previously published data (Lio et al., 2016), WT mice lost approximately 10% of weight by 3
days p.i. after which they recovered (Figure 1A). Here we observed that STING GT mice showed
more pronounced weight loss compared to WT mice, but were also able to recover. Consistent with
previously published data (Delale et al., 2005), MyD88 KO mice showed delayed weight loss as
compared to WT mice, indicating that the initial weight loss in WT mice was caused by immunopa-
thology mediated by MyD88. The weight curves of DKO mice overlapped with MyD88 KO mice,
suggesting that STING-mediated responses do not contribute to immunopathology. Both WT and
STING GT mice were able to control and survive viral infection upon challenge with MCMV
(Figure 1B). MyD88 KO mice were moderately resistant to the infection as 37% of the mice died
between days 6 and 7. In contrast, the majority (70%) of DKO mice succumbed to the infection.
Thus, both STING and MyD88 significantly contribute to control of MCMV infection in vivo.
STING contributes in both the hematological and radio-resistant
compartments in controlling viral load
To investigate the contribution of STING and MyD88 in different organs, we analyzed viral loads in
the spleen and liver, the initial organs of replication after infection (Hsu et al., 2009; Sacher et al.,
2008). In the spleen, we observed a modest but significant increase (6.9-fold) in viral load in MyD88
KO mice two days p.i., whereas the spleens of DKO mice contained 84-fold higher viral copies com-
pared to WT controls (Figure 2A). Consistent with previous studies (Lio et al., 2016), we observed a
3.5-fold increase in viral load in the spleens of STING GT versus WT controls, but this difference did
not reach statistical significance. By 5 days p.i. we observed an 85-fold increase in viral load in the
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Figure 1. MyD88 and STING control morbidity and mortality during MCMV infection. Mice were infected with 50,000 PFU MCMV WT-1, weight loss and
survival was monitored over time. (A) Weight loss over time in wildtype (n = 12), STING-deficient (STING GT, n = 21), MyD88-deficient (MyD88 KO,
n = 9) and mice deficient in both STING and MyD88 (DKO; n = 14). The numbers indicate the number of mice at the start of the experiment, weight
loss of surviving mice at each timepoint is plotted. (B) Survival curves of wildtype (n = 17), STING GT (n = 18), MyD88 KO (n = 17) and DKO mice
(n = 20). Cumulative data of 3 independent experiments. Error bars indicate SEM; *p<0.05, **p<0.01, ****p<0.0001.
The online version of this article includes the following source data for figure 1:
Source data 1. MyD88 and STING control morbidity and mortality during MCMV infection.
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spleens of MyD88-deficient and 1901-fold
increase in viral load in DKO, both as compared
to WT controls (Figure 2B). We did not observe
significant differences in STING-deficient ani-
mals, but we observed a 23-fold increase in viral
load in DKO spleens compared to MyD88 KO,
indicating that STING contributes to viral control
in the absence of MyD88. In the liver, we were
unable to detect significant differences in viral
load at 2 days p.i. (Figure 2A). By day 5, we
observed a 221-fold increase in DKO and 51-fold
increase in MyD88 KO viral load compared to
WT controls (Figure 2B). Taken together, these
data indicate that the STING and MyD88 path-
ways contribute to viral control at early time-
points, particularly in the spleen and to a lesser
extent in the liver.
MyD88 has been reported to be required in
the hematological compartment, but not in the
radio-resistant compartment (Puttur et al.,
2016), yet it is unclear which compartment(s)
requires STING-dependent pathways. To investi-
gate the contributions of STING and MyD88
dependent pathways in these compartments, we
generated bone marrow (BM) chimeras of either
or both knockout BM into irradiated WT or
STING GT hosts and analyzed viral load day 5
p.i. (Figure 2C). While WT hosts reconstituted
with WT BM controlled viral load similar to WT
control mice (Figure 2C vs Figure 2—figure
supplement 1A), reconstitution of WT hosts with
MyD88-deficient BM resulted in elevated viral
loads compared to reconstitution with WT BM
(Figure 2C), consistent with previously published
results (Puttur et al., 2016). We also observed
that the contribution of MyD88 in the hemato-
logical compartment was particularly overt in the
absence of STING, revealed by comparison of
DKO BM into STING GT host versus STING GT
BM into STING GT host, which resulted in a
3882-fold difference in the spleen and 344-fold
in the liver, respectively. STING also had anti-
viral effects in the hematological compartment,
evident by comparing DKO BM into STING GT
host versus MyD88 KO BM into STING GT host,
which revealed a 59-fold difference in the
spleen. STING played also a role in the radio-
resistant compartment in both spleen and liver,
revealed by comparison of DKO BM into WT
host versus DKO BM into STING GT host, for
which we observed a 49-fold and 24-fold differ-
ences in the spleen and liver, respectively.
Jointly, the BM chimeras reveal an evident role
for MyD88 in the hematological compartment,
while STING contributes to viral control in both
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Figure 2. STING contributes to control of MCMV in the
hematological and stromal compartment, whereas
MyD88 in the hematological compartment potently
controls infection. Mice were infected with 50,000 PFU
Figure 2 continued on next page
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the hematological and radio-resistant compart-
ments, most explicitly in the spleen.
Multiple cell populations produce
IFN-I in response upon MCMV
infection
Type I IFNs are induced in response to trigger-
ing of pathogen recognition receptors that sig-
nal through MyD88 and STING and are key
players in the initial anti-viral response. To inves-
tigate the IFN-I response in virus-infected cells
we made use of a reporter virus that expresses
GFP under the IE1 promoter (Henry et al.,
2000). We analyzed initial times (8- and 36 hours
p.i.) and focused on stromal cell and CD11c+
dendritic cell (DC) populations, which are the
major cell types infected at these timepoints
(Hsu et al., 2009). Consistent with previous pub-
lished data, we detected infection of the stromal
cell but not CD45+CD11c+ compartment at 8
hours p.i. (Figure 3A). At 36 hours p.i., the per-
centage of infected stromal cells increased sub-
stantially and infected CD45+CD11c+ cells were detected as well. Infected CD45+CD11c+ cells
included among others conventional dendritic cells (cDC) and plasmacytoid DC (pDC) populations.
Based on these data, we sorted and analyzed infected and uninfected populations at 36 hours p.i.
for IFNa and IFNb transcripts by quantitative PCR (Figure 3—figure supplement 1). The infected
stromal cells (GFP+) specifically expressed Ifna and Ifnb1 transcripts, which were not detected in the
uninfected (GFP-) cells (Figure 3B). Infected CD11c+ cells also expressed transcripts for Ifna and
Ifnb1 but high levels of Ifna transcripts were also detected in GFP- CD11c+ cells isolated from
MCMV-infected animals, while Ifnb1 transcripts were much lower in this population compared to
infected CD11c+ cells (Figure 3C). Thus, Ifnb1 expression correlated with infection status in CD45-
Figure 2 continued
(A) and (B) or 20,000 PFU (C) MCMV. Viral load was
quantified 2 days (A) or 5 days (B) and (C) p.i. (C)
Indicated bone marrow was adoptively transferred into
irradiated wildtype (WT) or STING-deficient (STING GT)
hosts. Bone marrow chimeras were infected 6 weeks
post transfer and viral load was analyzed 5 days p.i.
Each panel shows cumulative data of 2 independent
experiments. Error bars indicate SEM; ns, not
significant, *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
The online version of this article includes the following
source data and figure supplement(s) for figure 2:
Source data 1. STING contributes to control of MCMV
in the hematological and stromal compartment,
whereas MyD88 in the hematological compartment
potently controls infection.
Figure supplement 1. Viral load for 20,000 PFU
infection 5 days p.i. and extended statistical analysis for
bone marrow chimeras.
Figure 3. MCMV-infected cells specifically produce IFNb upon infection. WT mice were infected with 100,000 PFU MCMV IE1-GFP reporter virus. (A)
Analysis of GFP expression in CD45- stromal cells and CD45+CD11c+ DC at 8 hr and 36 hours p.i. (B) GFP+ and GFP- stromal cells and DC were FACS-
sorted 36 hours p.i. and Ifnb1 and pan-Ifna transcript levels were quantified by real-time PCR. Both panels show representative experiments from two
independent experiments. Error bars indicate SD; ns, not significant, *p<0.05, **p<0.01, ***p<0.001.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. MCMV-infected cells specifically produce IFNb upon infection.
Figure supplement 1. Gating strategy and purity of sorted cell populations.
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and CD45+CD11c+ cells, while Ifna did not correlate with infection in CD45+CD11c+ cells. Based on
these data we chose to investigate the role of STING and MyD88 on IFNb production by different
cell types.
IFNb is produced by pDCs in a MyD88-dependent but STING-
independent manner during infection
To evaluate the role of STING and MyD88 on IFNb production by individual cells upon infection, we
backcrossed MyD88 KO, STING GT, and DKO mice to the IFNb-YFP reporter mouse (Scheu et al.,
2008). Approximately 20% of the pDCs were YFP+, indicating at least this percentage of pDCs pro-
duced IFNb in response to MCMV infection, whereas much fewer cDCs produced IFNb because less
than 1% of cDCs were YFP+ (Figure 4B). Consistent with previous studies of primary pDC in vitro
and in vivo (Krug et al., 2004; Tomasello et al., 2018; Zucchini et al., 2008b), we observed that
the production of IFNb by pDCs was solely dependent on MyD88 because MyD88 KO mice were
unable to induce detectable YFP (IFNb) in pDCs. By contrast, here we found that STING GT mice
did not significantly affect pDC IFNb production, indicating that MyD88 functions in these cells with-
out requiring STING-dependent pathways. On the other hand, both STING and MyD88 seemed to
affect IFNb reporter levels in the few YFP+ cDCs, although the differences were not significant
(Figure 4B). Nonetheless, these results indicate that MyD88-dependent sensing of MCMV dictated
the IFNb response in pDCs, but it remained unclear how MyD88- and STING-dependent pathways
contribute to IFNb production in stromal cells.
IFNb is produced by stromal cells in a STING-dependent but MyD88-
independent manner during infection
Since we were unable to find YFP+ infected stromal cells, which might be due to a detection level
issue in these cells in vivo (Figure 4), we turned to in vitro infection of primary splenic fibroblasts
and challenged them with MCMV at MOI 5 (Figure 5A). Indeed, splenic fibroblasts readily expressed
8000-fold increase in Ifnb1 transcripts by qPCR at 8 hours p.i. To determine the role of key innate
sensing components, we used mouse embryonic fibroblasts (MEFs) that were genetically deficient in
these components. Consistent with primary splenic fibroblasts, MEF expressed Ifnb1 transcripts
upon MCMV infection (Figure 5B), reaching levels similar to those detected in primary splenic fibro-
blasts. We further observed that Ifnb1 expression was independent of MyD88 and TRIF, indicating
that TLRs do not contribute to IFNb production in fibroblasts even though Ifnb1 expression was
dependent on IRF3/7 and TBK1, which is consistent with cytosolic sensing of MCMV. Using MEF
lines with two different mutations in STING (Ishikawa and Barber, 2008; Sauer et al., 2011), we
found that the IFNB1 response was instead dependent on STING. However, IFNB1 production was
independent of MAVS (also known as CARDIF and IPS-1), suggesting that the IFN-response is inde-
pendent of the cytosolic RNA sensors (Tan et al., 2018). Finally, we investigated the role of cytosolic
DNA sensors and found that fibroblast sensing of MCMV was dependent on cGAS, but independent
of ZBP1 and DNA-PK. To confirm that the cGAS pathway is involved in adult splenic stromal cells,
we analyzed Ifnb1 expression in cGAS-deficient primary splenic fibroblasts (Figure 5C). Indeed,
cGAS-deficient splenic fibroblasts were unable to express Ifnb1 in response to MCMV challenge,
indicating that the STING-cGAS-dependent pathway is responsible for the IFNb response in the stro-
mal cell compartment. To validate that these pathways are also involved in IFNb protein production
and secretion, we analyzed cell culture supernatants at 48 hours p.i. with MCMV MOI 0.5
(Figure 5D). WT MEF secreted IFNb in response to MCMV infection, but neither STING nor cGAS-
deficient MEFs produced IFNb. Collectively, these results strongly suggest that the stromal cell com-
partment produces IFNb in a STING-cGAS dependent but MyD88-independent manner.
MyD88 and STING contribute to NK cell cytolytic potential
We previously reported that both IFN-I and IL-12 act directly on NK cells to induce perforin (Prf) and
granzyme B (GzB) protein levels, thereby increasing NK cell cytolytic potential, which was required
for Ly49H-dependent control of MCMV infection (Parikh et al., 2015). Moreover, IL-12 production
in response to MCMV has been reported to be dependent on MyD88 (Krug et al., 2004), and thus
contributed to the phenotypes observed in MyD88 KO mice independent of IFN-I. Here we investi-
gated the role of MyD88 and STING in increasing NK cell reactivity during MCMV infection.
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Consistent with previous reports (Fehniger et al., 2007; Orange et al., 1995; Parikh et al., 2015),
we observed increased levels of NK cell GzB, Prf and IFNg at 48 hours p.i. (Figure 6A). At this time
point, NK cell production of IFNg is reportedly dependent on IL-18, which signals through MyD88
(Adachi et al., 1998; Pien et al., 2000). Indeed, NK cell IFNg production was dependent on MyD88,
whereas STING did not impair IFNg production, and rather increased the IFNg response (Figure 6B).
This potentially could be due to a relatively small increase in viral load at these timepoints. Expres-
sion of both GzB and Prf followed a similar pattern, as the vast majority of increased expression was
dependent on MyD88, whereas STING did not overtly contribute to the production of these lytic
proteins (Figure 6B). Finally, we analyzed NK cell cytolytic capacity using a 3 hr in vivo target cell
rejection assay. We previously reported that MCMV increased m157-target cell rejection in an IL-12-
and IFN-I-dependent manner (Parikh et al., 2015). Consistent with our previous data, m157-specific
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Figure 4. pDCs produce IFNb in a MyD88-dependent but STING-independent manner in IFNb-YFP reporter mice.
IFNb-YFP reporter mice were backcrossed to MyD88- (MyD88 KO), STING- (STING GT) and double-deficient
(DKO) mice. Animals were infected with 200,000 PFU WT1 MCMV and analyzed 48 hr post infection. Spleens were
digested to a single cell suspension, stained and analyzed by flow cytometry. Error bars indicate SD; **p<0.01.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. pDCs produce IFNb in a MyD88-dependent but STING-independent manner in IFNb-YFP reporter
mice.
Figure supplement 1. Gating strategy for analysis of IFNb-YFP reporter mice.
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Figure 5. MCMV-induced fibroblast IFNb is triggered by cGAS-STING-dependent but MyD88-Trif-MAVS-
independent mechanisms. (A) IFNB1 mRNA levels of primary splenic fibroblasts infected with WT1 MCMV
(MOI = 5) 8 hr post-infection. (B) IFNB1 mRNA levels of murine embryonic fibroblasts (MEF) from wildtype (WT) or
indicated deficient mice were infected and analyzed as in (A). (C) IFNB1 mRNA levels in infected WT or cGAS-
deficient primary splenic fibroblasts, analyzed as in (A). (D) Secreted IFNb by WT or indicated gene deficient MEF,
infected with MCMV (MOI = 0.5); supernatant was analyzed 48 hours p.i. by ELISA. Panels show representative
experiments from two independent experiments performed in duplicate. WT, STING GT, and TBK1-, MAVS-,
Figure 5 continued on next page
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target cell rejection increased 3 days post-MCMV infection from 50% to 80% (Figure 6C). MHC-I-
deficient cell (‘missing self’) rejection was higher and increased from 30% to 90%. MyD88 KO or
STING GT mice did not display substantial differences in target cell rejection, but DKO mice sub-
stantially decreased NK cell cytolytic capacity with m157-specific rejection showing levels of unin-
fected mice. Similarly, MHC-I-deficient rejection was decreased in double versus single deficient
mice. Together, these data indicate that both MyD88 and STING-dependent pathways contribute to
NK cell cytolytic potential, albeit that MyD88 predominantly affects production of Prf and GzB.
Discussion
Herein we describe that MCMV infection can be sensed by both STING and MyD88-dependent
pathways which contribute to viral control in response to lethal challenge. While we confirmed the
strong role of MyD88 in the hematological compartment, especially in splenic pDCs, we found that
STING contributes in both the hematological and the previously unappreciated stromal cell compart-
ment. Using primary splenic stromal cell cultures, we identified a role for cGAS-STING-dependent,
but MyD88-independent IFN-I production in response to MCMV infection. Finally, we found that
both MyD88 and STING-dependent pathways contribute to increased NK cell cytolytic function dur-
ing infection. Thus, our findings indicate that cytomegalovirus infection is sensed by distinct sensing
pathway depending on the infected cell type and that these pathways constitute a multi-layer antivi-
ral defense.
Cytomegaloviruses have a broad tropism and a broad range of infected cell types have the
capacity to produce IFN-I in response to infection. However, IFN-I production has been most well
characterized in myeloid cells, including pDCs and Kupffer cells. IFN-I production by pDCs upon
MCMV infection in vitro and in vivo is dependent on TLR9 and MyD88 (Krug et al., 2004;
Tomasello et al., 2018; Zucchini et al., 2008b). Using IFNb reporter mice, we were able to confirm
that pDCs were the major source of IFNb in the spleen and that this was dependent on MyD88. Fur-
thermore, we observed that this IFN-I production was independent of STING. Early after infection,
Kupffer cells in the liver produce IFN-I in a STING-dependent, but TLR-independent manner
(Tegtmeyer et al., 2019). Hepatocytes are a major target for infection by MCMV (Sacher et al.,
2008), yet they do not induce detectable levels of IFNb (Tegtmeyer et al., 2019). However, hepato-
cytes do not express STING (Thomsen et al., 2016), likely explaining the lack of IFNb production in
hepatocytes in response to MCMV infection. In our bone marrow chimeras, we observed a role for
STING in the radioresistant compartment in the liver. Hepatic stromal cells, including endothelial
cells, are infected with MCMV (Sacher et al., 2008), providing likely contributors, apart from hepato-
cytes per se, to control MCMV in a STING-dependent manner in the liver.
MCMV is known to induce strong MyD88-dependent IFN-I responses in pDCs (Krug et al., 2004;
Zucchini et al., 2008a). Consistent with these results, we observed both Ifna and Ifnb1 transcripts,
particularly in infected CD45+CD11c+ cells. We also observed equal expression of Ifna in the unin-
fected compartment. IFNa as well as IL-12 have been shown previously to be primarily produced by
purified pDCs that were not productively infected (Dalod et al., 2003). Intriguingly, Ifnb1 transcripts
were much lower in the uninfected compartment as compared to the infected compartment. There
was a trend in increased Ifnb1 transcripts in uninfected CD11c+ cells from infected versus uninfected
mice, but this did not reach statistical significance. The observed difference in IFNa versus IFNb pro-
duction is remarkable; specifically, the IFN-I production by the pDCs that are not productively
infected could be due to multiple reasons. IFN-I can act to produce more IFN-I as part of a positive
feedback loop (McNab et al., 2015). However, this loop does not appear to play a major role in
pDC after MCMV infection, as IFN-I receptor-deficient pDC in mixed bone marrow chimeras express
similar levels of Ifna and Ifnb1 as WT pDC (Tomasello et al., 2018). The Ifna production by the
Figure 5 continued
ZBP1-, DNA-PK-, and cGAS-deficient MEF represent data from two independent MEF preparations. Error bars
indicate SEM; ns, not significant, *p<0.05, **p<0.01, ***p<0.001.
The online version of this article includes the following source data for figure 5:
Source data 1. MCMV-induced fibroblast IFNb is triggered by cGAS-STING-dependent but MyD88-Trif-MAVS-
independent mechanisms.
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Figure 6. MyD88 and STING are required for NK cell cytolytic capacity during MCMV infection. (A and B) Mice
deficient in MyD88 and/or STING were infected with MCMV and 2 days later splenocytes were harvested and
analyzed for GzmB, Prf1, and IFNg expression by FACS. Representative contour plots of individual mice are shown
in (A) and quantification for multiple mice is shown in (B). (C) Differentially labelled WT, m157-Tg and MHC-I
deficient splenocytes were adoptively transferred into indicated day 3-infected mice. Specific rejection was
Figure 6 continued on next page
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uninfected CD11c+ cells could be the result of non-productive infection that did not result in IE1ex-
pression that was used to detect infected GFP+ cells. Alternatively, pDC may take up apoptotic bod-
ies from infected cells or pDC may receive other signals delivered by neighboring infected cells.
Which of these or other causes underlie IFN-I production by uninfected (GFP-) cells warrants further
investigation.
We observed a stronger effect of STING in the splenic stromal cell compartment compared to
the liver stromal cell compartment. IFN-I produced by splenic stromal cells have previously been
reported to be dependent on lymphotoxin (LT) b expression by B cells, independent of TLR signaling
(Sacher et al., 2008). Consistent with these findings, our findings revealed that stromal cell IFN-I is
cGAS-STING-dependent. Besides the anti-viral role for STING in the stromal cell compartment, we
observed that IFN-I production by infected primary splenic stromal cells was cGAS-STING-depen-
dent. The primary stromal cells did not require interactions with B cells to produce IFN-I in vitro.
However, it remains to be determined how LT intersects with the STING pathway in vivo, particularly
since LT has been reported to be required for cell survival during MCMV infection (Banks et al.,
2005), potentially providing a window where infected stromal cells survive long enough to produce
IFN-I. Additional studies are required to further define these experimentally complex interactions.
Herpesviruses dedicate a large part of their genome to immune evasion strategies, including
strategies that act on cellular immunity and intrinsic cellular defenses (Powers et al., 2008). MCMV
has been reported to interfere with the DNA sensing pathway at different steps, m152 binds to
STING and interferes with its trafficking (Stempel et al., 2019), whereas m35 targets NFkB-medi-
ated transcription (Chan et al., 2017). Deletion of these ORFs individually in MCMV resulted in
stronger IFN-I responses upon infection in vivo. Infection with MCMV deleted in both ORFs poten-
tially increased STING-dependent viral control and may facilitate visualization of the IFN-I production
by the cell types under study. Despite these immune evasion strategies, WT MCMV induced an IFN-I
response that was potent enough to control infection, therefore we chose to use WT MCMV in the
current study.
Infection with lethal dose of MCMV resulted in about a third of the MyD88-deficient mice suc-
cumbing to infection, which is consistent with previously published results (Delale et al., 2005). The
impact of MyD88-deficiency on mortality and viral load was greater than STING-deficiency, which
coincided with a bigger proportion of the IFN-I response was dependent on MyD88 as compared to
STING. Consistent with these findings, markers for NK cell activation were mostly MyD88-depen-
dent, whereas STING did not have a strong effect. Taken together, our data suggest that MyD88
induces a strong IFN-I response, whereas STING mediates a more moderate IFN-I response, likely
contributing to more moderate morbidity in its absence as compared to MyD88-deficency. A recent
study did not observe a lethality phenotype in mice deficient in MyD88 and TRIF, unless mice also
lacked MAVS (Tegtmeyer et al., 2019). The latter study utilized tissue culture-derived MCMV in
contrast to salivary gland extracted MCMV in the former and our study. Additionally, Tegtmeyer
et al. used a mutant MCMV that lacked m157, whereas we used m157-sufficient virus for infections
monitoring survival. Since IFN-I impacts NK cell-dependent MCMV-control via m157 recognition
(Parikh et al., 2015), the use of WT MCMV allowed us to evaluate the effect of the virus-sensing
pathways on NK cell function.
MyD88 KO mice have been reported to have a delay in initial weight loss (Delale et al., 2005),
we observed a similar delay in weight loss in MyD88 KO and in DKO mice. STING did not cause any
such overt immunopathology, indicating that this phenomenon may be specific to MyD88-depen-
dent pathways. Moreover, the immunopathology is likely independent of IFN-I as a recent study
showed that IFNAR-deficient mice still displayed early weight loss (Tegtmeyer et al., 2019). Addi-
tional research is required to better understand the MyD88-mediated initial weight loss in MCMV
infected animals.
Figure 6 continued
analyzed 3 hr post-transfer in the spleen. Representative experiments from two independent experiments per
panel are shown. Error bars indicate SEM; ns, not significant, *p<0.05, **p<0.01, ***p<0.001.
The online version of this article includes the following source data for figure 6:
Source data 1. MyD88 and STING are required for NK cell cytolytic capacity during MCMV infection.
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IFN-I and IL-12 produced in response to MCMV infection are required for full NK cell cytolytic
capacity, through induction of GzB and Prf (Parikh et al., 2015). Consistent with previous reports
(Krug et al., 2004; Puttur et al., 2016), we found that MyD88-deficient mice expressed low levels
of NK cell GzB, Prf and IFNg in response to MCMV infection but NK cytolytic potential in vivo was
not substantially affected, consistent with previously published results (Cocita et al., 2015). How-
ever, MCMV-infected mice deficient in both STING and MyD88 displayed reduced NK cell cytolytic
activity against m157-expressing and MHC-I-deficient target splenocytes. Thus, MyD88- and STING-
dependent sensing of MCMV both contribute to signal to NK cells to enhance their cytolytic function
in order to efficiently clear MCMV-infected target cells.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain, C57BL/6
background
(Mus musculus)
C57BL/6 Charles River
Laboratories
556;
RRID:MGI:2160593
Strain, BALB/c
background
(Mus musculus)
BALB/c Charles River
Laboratories
555;
RRID:MGI:2160915
Strain, C57BL/6
background
(Mus musculus)
STING
golden ticket
Jackson
Laboratories
017537;
RRID:IMSR_JAX:017537
Strain, C57BL/6
background
(Mus musculus)
IFNb-YFP
reporter mice
Jackson
Laboratories
010818;
RRID:IMSR_JAX:010818
Strain, C57BL/6
background
(Mus musculus)
DNA-PK SCID Jackson
Laboratories
001913;
RRID:IMSR_JAX:001913
Strain, C57BL/6
background
(Mus musculus)
B2m KO Jackson
Laboratories
002087;
RRID:IMSR_JAX:002087
Strain, C57BL/6
background
(Mus musculus)
M157-Tg Tripathy et al., 2008
Strain, C57BL/6
background
(Mus musculus)
H-2Kb x H-2Db KO Taconic 4215;
RRID:IMSR_TAC:4215
Strain, C57BL/6
background
(Mus musculus)
MyD88 KO S. Akira RRID:MGI:3577712 through the JCRB
Laboratory Animal Resource
Bank of the National
Institute of Biomedical
Innovation
Strain, C57BL/6
background
(Mus musculus)
TBK1 KO S. Akira nbio156;
RRID:MGI:3053427
through the JCRB
Laboratory Animal Resource
Bank of the National
Institute of Biomedical
Innovation
Strain, C57BL/6
background
(Mus musculus)
ZBP1 KO S. Akira nbio155;
RRID:MGI:3776852
through the JCRB
Laboratory Animal
Resource Bank of the
National Institute of
Biomedical Innovation
Strain, C57BL/6
background
(Mus musculus)
IPS1 KO Michael Gale
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain, C57BL/6
background
(Mus musculus)
cGAS KO Herbert Virgin
Other IRF3/7 KO MEF Michael Diamond Primary murine
embryonic fibroblasts.
Other STING KO MEF Glen Barber Primary murine
embryonic fibroblasts.
Other MyD88xTRIF KO MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other TBK1 KO MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other TBK1 HET MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other STING GT MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other MAVS (IPS1) KO MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other MAVS (IPS1)
KO MEF
This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other MAVS (IPS1)
KO MEF
This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other ZBP1 KO MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other DNA-PKSCID MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Other cGAS KO MEF This paper Primary murine
embryonic fibroblasts.
See Materials and
methods, Section 2
Virus
(murine
cytomegalovirus)
MCMV WT1 Cheng et al., 2010
Virus
(murine
cytomegalovirus)
MCMV GFP Henry et al., 2000
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Sequence-
based reagent
MCMV IE1 IDT DNA TAQman assay Forward: 5’-
CCCTCTCCTAACTCTCCCTTT-3’;
Reverse: 5’-
TGGTGCTCTTTTCCCGTG  3’;
Probe: 5’-
TCTCTTGCCCCGTCCTGAAAACC-3’
Sequence-
based reagent
ACTB IDT DNA TAQman assay Forward: 5’-
AGCTCATTGTAGAAGGTGTGG-3’;
Reverse: 5’-
GGTGGGAATGGGTCAGAAG-3’;
Probe: 5’-
TTCAGGGTCAGGATA
CCTCTCTTGCT-3’
Sequence-
based reagent
IFNB1 Thermo
Fisher Scientific
TAQman assay Mm00439546_s1
Sequence-
based reagent
(pan)Ifna IDT DNA TAQman assay Forward: 5’-
CTTCCACAGGATC
ACTGTGTACCT-3’;
Reverse: 5’-
TTCTGCTC TGACCACCTCCC-3’;
Probe: 5’-
AGAGAGAAGAAACACAGCCC CTGTGCC-3’
Sequence-
based reagent
GAPDH Thermo
Fisher Scientific
TAQman assay Mm99999915_g1
Antibody Anti-mouse NK1.1
PE-Cy7 (Mouse
monoclonal)
Thermo
Fisher Scientific
Cat#: 25-5941-82;
RRID:AB_469665
FACS (1:100)
Antibody Anti-mouse NKp46
PerCP-eFluor710
(Rat monoclonal)
Thermo
Fisher Scientific
Cat#: 46-3351-82;
RRID:AB_1834441
FACS (1:100)
Antibody Anti-mouse CD3
APC-eFluor780
(Armenian hamster
monoclonal)
Thermo
Fisher Scientific
cat# 47-0031-82,
RRID:AB_11149861
FACS (1:100)
Antibody Anti-mouse CD19
APC-eFluor780
(Rat monoclonal)
Thermo Fisher
Scientific
Cat# 47-0193-82,
RRID:AB_10853189
FACS (1:100)
Antibody Ly49H FITC
(Mouse monoclonal)
Made in-house FACS (1:200)
Antibody Anti-mouse CD31 PE
(Rat monoclonal)
Thermo Fisher
Scientific
Cat# 12-0311-83,
RRID:AB_465633
FACS (1:100)
Antibody Anti-mouse PDCA1
PE (Mouse monoclonal)
Thermo Fisher
Scientific
Cat# 12-3171-81,
RRID:AB_763427
FACS (1:50)
Antibody Anti-mouse gp38
PE-Cy7 (Syrian
hamster monoclonal)
Thermo Fisher
Scientific
Cat# 25-5381-82,
RRID:AB_2573460)
FACS (1:100)
Antibody Anti-mouse CD45
APC (Rat monoclonal)
Thermo Fisher
Scientific
Cat# 17-0451-83,
RRID:AB_469393)
FACS (1:50)
Antibody Anti-mouse CD11c
APC-eFluor780
(Armenian hamster
monoclonal)
Thermo Fisher
Scientific
Cat# 47-0114-82,
RRID:AB_1548652)
FACS (1:50)
Antibody Anti-mouse Ly49H
APC (Mouse
monoclonal)
Thermo Fisher
Scientific
Cat# 17-5886-82,
RRID:AB_10598809
FACS (1:100)
Antibody Anti-mouse Perforin
PE (Rat monoclonal)
Thermo Fisher
Scientific
Cat# 12-9392-82,
RRID:AB_466243
FACS (1:50)
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody Anti-mouse Granzyme
B APC (Mouse
monoclonal)
Thermo Fisher
Scientific
Cat# MHGB05,
RRID:AB_10373420
FACS (1:100)
Antibody Anti-mouse IFNg
eFluor450 (Rat
monoclonal)
Thermo Fisher
Scientific
Cat# 48-7311-82,
RRID:AB_1834366
FACS (1:100)
Commercial
assay or kit
Mouse
IFNB ELISA
Biolegend 439407
Commercial
assay or kit
Cytofix/
Cytoperm kit
BD Biosciences 554714
Software,
algorithm
Prism Graphpad RRID: SCR_002798
Software,
algorithm
Flowjo Treestar Inc RRID:SCR_008520
Other Viability stain
eFluor 506
Thermofisher
Scientific
65-0866-14 FACS (1:1000)
Mice
C57BL/6 (stock number 556) and BALB/c (555) mice were purchased from Charles River Laborato-
ries. The following mouse strains were purchased from Jackson Laboratories: STING golden ticket
(Sting1 <gt > ; 017537), IFNb-YFP reporter mice (Ifnb1; 010818), DNA-PK SCID (Prkdc <scid > ;
001913), and b2m KO (B2m; 002087) all on the C57BL/6 background. m157-Tg mice were generated
and maintained in-house on the C57BL/6 background (Tripathy et al., 2008). H-2Kb KO x H-2Db KO
(H2-k1 x H2-d1; 4215) mice on the C57BL/6 background were purchased from Taconic Farms.
MyD88 KO (Myd88), TBK1 KO (Tbk1; nbio156), and ZBP1 KO (Zbp1; nbio155) mice were kindly pro-
vided by S. Akira (Osaka University, Osaka, Japan) through the JCRB Laboratory Animal Resource
Bank of the National Institute of Biomedical Innovation (Adachi et al., 1998; Hemmi et al., 2004;
Ishii et al., 2008) and were maintained on a C57BL/6 background. IPS1 KO (Mavs) mice on the
C57BL/6 background were kindly provided by Michael Gale (University of Washington, Seattle, WA,
USA). Mice deficient for cGAS (Cgas) were kindly provided by Herbert Virgin (Vir Biotechnology, San
Francisco, CA, USA) (Schoggins et al., 2014). Triple MHC Class I KO mice (TKO) were generated by
crossing b2m KO mice to H-2Kb KO x H-2Db KO mice. STING GT mice were crossed to MyD88 KO
to generate DKO mice. Subsequently DKO and single KO mice were crossed with IFNb-YFP reporter
to generate IFNb-YFP on the various KO backgrounds. All mice were maintained in-house in accor-
dance with institutional ethical guidelines. Age- and sex-matched mice were used in all experiments.
Cell lines
3T12 cells (ATCC CCL-164) were maintained in DMEM supplemented with newborn calf serum,
L-glutamine, penicillin, and streptomycin and were used for production of tissue culture derived
MCMV and tittering of virus stocks. All MEF were maintained in RPMI supplemented with fetal
bovine serum, L-glutamine, penicillin, and streptomycin. IRF3/7 KO MEF were kindly provided by
Michael S Diamond (Washington University in St Louis, MO, USA). STING KO MEF have been
described before (Ishikawa et al., 2009). All other MEF lines were generated from day 11.5–13.5
embryos, at least two independent lines were generated per genotype. To generate splenic fibro-
blasts, spleens were minced and digested with Liberase TL, adherent cells were cultured for 3–6
weeks to obtain pure fibroblast populations.
In vivo virus infections
For in vivo studies salivary gland MCMV (sg-MCMV) of the WT-1 strain, a subcloned Smith strain
(Cheng et al., 2010), was used for infections unless otherwise indicated. Where indicated, MCMV
that expressed GFP under the IE1 promotor was used to visualize infected cells (Henry et al., 2000).
This reporter virus contained a mutation in m157. All viral strains for in vivo infections were
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propagated in BALB/c mice; virus was isolated from salivary glands and titers were determined as
previously described (Brune et al., 2001; Jonjic, 2001). Mice were infected with indicated dose of
MCMV intraperitoneally in 200 ml PBS. For survival studies weight was monitored daily and mice
were sacrificed when more than 30% of initial weight was lost, in accordance to animal protocol.
Viral load analysis was performed as previously described (Parikh et al., 2015). Briefly, RNA-free
organ DNA was isolated using Puregene extraction kit (Qiagen). 160 ng DNA was quantified for
MCMV IE1 (Forward: 5’-CCCTCTCCTAACTCTCCCTTT-3’; Reverse: 5’-TGGTGCTCTTTTCCCGTG
 3’; Probe: 5’-TCTCTTGCCCCGTCCTGAAAACC-3’; IDT DNA) and host Actb (Forward: 5’- AGC
TCATTGTAGAAGGTGTGG-3’; Reverse: 5’- GGTGGGAATGGGTCAGAAG-3’; Probe: 5’-TTCAGGG
TCAGGATACCTCTCTTGCT-3’; IDT DNA) against plasmid standard curves using TAQman universal
master mix II on a StepOnePlus real time PCR system (Thermo Fisher Scientific).
Bone marrow chimeras
C57BL/6 and STING GT mice were irradiated with 950 rad by an x-ray irradiator and were intrave-
nously with 5 million of the indicated genotype donor bone marrow cells. Chimeric mice were given
antibiotic water (sulfamethoxazole/trimethoprim) for 4 weeks. 6 weeks post-irradiation mice were
infected with MCMV and analyzed for viral load at 5 days p.i. We observed greater sensitivity of
reconstituted BM chimeric mice to infections than mice not subjected to the BM transplant proce-
dure in our facility so we infected reconstituted mice with a lower dose of MCMV (20,000 PFU) as
compared to non-chimeric mice.
In vitro virus infections
For in vitro studies, pelleted tissue culture-derived MCMV was prepared and viral titers were deter-
mined as previously described (Brune et al., 2001). 200,000 cells were plated in a 6-well plate over-
night and were infected with 200 ml of MCMV at MOI five for RNA analysis and MOI 0.5 for
supernatant analysis for 1 hr, after which wells were washed with PBS to remove free virus and 2 ml
fresh culture media was added. Cells were lysed in the wells with 1 ml trizol after an additional 5 hr
culture for RNA analysis. Samples were stored at  80˚C until analysis. Supernatants were harvested
48 hr after culture and analyzed for IFNb by ELISA (Biolegend) according to manufacturer protocol.
Flow cytometry
Fluorescent-labeled antibodies used were anti-NK1.1 (clone PK136), anti-NKp46 (29A1.4), anti-CD3
(145–2 C11), anti-CD19 (eBio1D3), anti-CD31 (390), anti-PDCA1 (eBio129c), anti-gp38 (eBio8.1.1),
anti-CD45 (30-F11), anti CD11c (N418), anti-Ly49H (3D10), anti-Perforin (eBioOMAK-D), anti-Gran-
zyme B (GB12), and anti-IFNg (XMG1.2), all from Thermo Fisher Scientific. For analysis of splenic
dendritic and stromal cells, spleens were digested with 1 mg/ml Liberase TL and DNAse -I (Millipore
Sigma) for 45 min with mechanical dissociation with a pipette every 15 min to obtain a single cell
suspension. For analysis of NK cells, spleens were crushed through a 70 mm cell strainer to obtain a
single cell suspension. Red blood cells (RBC) in all samples were lysed with RBC lysis buffer. Cells for
analysis were first stained with fixable viability day (Thermo Fisher Scientific). Subsequently, cell sur-
face molecules were stained in 2.4G2 hybridoma supernatant to block Fc receptors. For intracellular
staining, cells were fixed and stained intracellularly using the Cytofix/Cytoperm kit (BD Biosciences)
according to manufacturer’s instructions. Samples were acquired using FACSCanto (BD Biosciences)
and analyzed using FlowJo software (Treestar). NK cells were defined as Viability-NK1.1+CD3-CD19-.
Where indicated, cells were sorted on a FACSaria (BD Biosciences) into media and subsequently
lysed in Trizol for RNA analysis.
RNA analysis
RNA was isolated from cultured or sorted cells using Trizol according to manufacturer instruction
(Thermo Fisher Scientific). Contaminating DNA was removed using Turbo DNAse, and cDNA was
synthesized using Superscript III using oligo(dT) (Thermo Fisher Scientific). Quantification was per-
formed for Ifnb1 (Mm00439546_s1; Thermo Fisher Scientific), (pan)Ifna (Forward: 5’-CTTCCA-
CAGGATCACTGTGTACCT-3’; Reverse: 5’-TTCTGCTC tgaccacctccc-3’; Probe: 5’-
AGAGAGAAGAAACACAGCCC CTGTGCC-3’; IDT DNA) (Samuel and Diamond, 2005) and Gapdh
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(Mm99999915_g1; Thermo Fisher Scientific) against plasmid or pooled standard curves using TAQ-
man universal master mix II on a StepOnePlus real time PCR system (Thermo Fisher Scientific).
In vivo cytotoxicity assay
Target splenocytes were isolated from C57BL/6, m157-Tg, and MHC-I deficient (TKO) mice and dif-
ferentially labelled with CFSE, CellTrace violet, and CellTrace far red (Thermo Fisher Scientific). Tar-
get cells were mixed at a 1:1:1 ratio and 3  106 target cells were injected i.v. into naı̈ve or day 3
MCMV-infected mice. 3 hr after challenge splenocytes were harvested and stained. The ratio of tar-
get (m157-tg or TKO) to control (C57BL/6) viable CD19+ cells was determined by flow cytometry.
Target cell rejection was calculated using the formula [(1 (Ratio(target:control)sample/Ratio(target:
control)NK depleted))100]. Average of two NK1.1-depleted mice served as control.
Statistical analysis
Statistical analysis was performed using Prism (GraphPad software). Survival curves were compared
using Log-Rank (Mantel-Cox) tests, other comparisons were performed using one-way ANOVA with
Bonferroni’s multiple comparisons tests to calculate P values. Error bars in figures represent the
SEM. Statistical significance was indicated as follows: ****, p<0.0001; ***, p<0.001; **, p<0.01; *,
p<0.05; ns, not significant.
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J, Lienenklaus S, Reddehase MJ, Jonjić S, Brinkmann MM. 2017. The murine Cytomegalovirus M35 protein
antagonizes type I IFN induction downstream of pattern recognition receptors by targeting NF-kB mediated
transcription. PLOS Pathogens 13:e1006382. DOI: https://doi.org/10.1371/journal.ppat.1006382, PMID: 2
8542326
Chapgier A, Kong XF, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, Zhang SY, Bustamante J, Vogt G,
Lejeune J, Mayola E, de Beaucoudrey L, Abel L, Engelhard D, Casanova JL. 2009. A partial form of recessive
STAT1 deficiency in humans. Journal of Clinical Investigation 119:1502–1514. DOI: https://doi.org/10.1172/
JCI37083, PMID: 19436109
Cheng TP, Valentine MC, Gao J, Pingel JT, Yokoyama WM. 2010. Stability of murine Cytomegalovirus genome
after in vitro and in vivo passage. Journal of Virology 84:2623–2628. DOI: https://doi.org/10.1128/JVI.02142-
09, PMID: 20015993
Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, Lafaille FG, Trouillet C, Schmolke M, Albrecht RA,
Israelsson E, Lim HK, Casadio M, Hermesh T, Lorenzo L, Leung LW, Pedergnana V, Boisson B, Okada S, Picard
C, et al. 2015. Infectious disease Life-threatening influenza and impaired interferon amplification in human IRF7
deficiency. Science 348:448–453. DOI: https://doi.org/10.1126/science.aaa1578, PMID: 25814066
Piersma et al. eLife 2020;9:e56882. DOI: https://doi.org/10.7554/eLife.56882 18 of 21
Research article Immunology and Inflammation Microbiology and Infectious Disease
Cocita C, Guiton R, Bessou G, Chasson L, Boyron M, Crozat K, Dalod M. 2015. Natural killer cell sensing of
infected cells compensates for MyD88 deficiency but not IFN-I activity in resistance to mouse Cytomegalovirus.
PLOS Pathogens 11:e1004897. DOI: https://doi.org/10.1371/journal.ppat.1004897, PMID: 25954804
Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, Biron CA. 2003. Dendritic cell
responses to early murine Cytomegalovirus infection: subset functional specialization and differential regulation
by interferon alpha/beta. The Journal of Experimental Medicine 197:885–898. DOI: https://doi.org/10.1084/
jem.20021522, PMID: 12682109
de Weerd NA, Vivian JP, Nguyen TK, Mangan NE, Gould JA, Braniff SJ, Zaker-Tabrizi L, Fung KY, Forster SC,
Beddoe T, Reid HH, Rossjohn J, Hertzog PJ. 2013. Structural basis of a unique interferon-b signaling Axis
mediated via the receptor IFNAR1. Nature Immunology 14:901–907. DOI: https://doi.org/10.1038/ni.2667,
PMID: 23872679
Delale T, Paquin A, Asselin-Paturel C, Dalod M, Brizard G, Bates EE, Kastner P, Chan S, Akira S, Vicari A, Biron
CA, Trinchieri G, Brière F. 2005. MyD88-dependent and -independent murine Cytomegalovirus sensing for IFN-
alpha release and initiation of immune responses in vivo. The Journal of Immunology 175:6723–6732.
DOI: https://doi.org/10.4049/jimmunol.175.10.6723, PMID: 16272328
Duncan CJ, Mohamad SM, Young DF, Skelton AJ, Leahy TR, Munday DC, Butler KM, Morfopoulou S, Brown JR,
Hubank M, Connell J, Gavin PJ, McMahon C, Dempsey E, Lynch NE, Jacques TS, Valappil M, Cant AJ, Breuer
J, Engelhardt KR, et al. 2015. Human IFNAR2 deficiency: lessons for antiviral immunity. Science Translational
Medicine 7:307ra154. DOI: https://doi.org/10.1126/scitranslmed.aac4227, PMID: 26424569
Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, Ley TJ. 2007. Acquisition of murine NK cell
cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26:
798–811. DOI: https://doi.org/10.1016/j.immuni.2007.04.010, PMID: 17540585
Gil MP, Bohn E, O’Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. 2001. Biologic
consequences of Stat1-independent IFN signaling. PNAS 98:6680–6685. DOI: https://doi.org/10.1073/pnas.
111163898, PMID: 11390995
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